Murray Jason Hulse sold 51,887 PACS Group shares across five transactions priced from $42.68 to $43.59 per share between 2026-09-04 and 2026-09-09. The transactions matter to investors because the disclosure identifies his remaining PACS Group holding as 54,574,866 shares.
Key Highlights
- The five transactions were reported under SEC transaction code S.
- The sales occurred between 4 September 2026 and 9 September 2026.
- Murray Jason Hulse is PACS Group’s co-founder, CEO and Chairman.
PACS Group, Inc. (NYSE: PACS) CEO and Chairman Murray Jason Hulse sold 51,887 shares across five transactions priced from $42.68 to $43.59 per share. The sales leave Hulse with 54,574,866 PACS Group shares.
Five Sales Recorded
The transactions took place between 4 September 2026 and 9 September 2026. The reported trades covered five separate transactions rather than a single sale. The price range for the shares extended from $42.68 to $43.59 per share. Following the transactions, Hulse’s reported ownership stood at 54,574,866 shares.
Reported Post-Sale Ownership
After the five transactions, the reported holding associated with Hulse was 54,574,866 shares. PACS Group’s transaction details identify both the aggregate shares sold and the remaining share count.
FAQs
Q: How many PACS Group shares did Murray Jason Hulse sell?
A: Murray Jason Hulse sold 51,887 PACS Group shares across five transactions. The reported sale prices ranged from $42.68 to $43.59 per share.
Q: When did the PACS Group insider sales occur?
A: The PACS Group transactions occurred between 4 September 2026 and 9 September 2026. The filing reports all five sales under SEC transaction code S.
Q: How many PACS Group shares does Murray Jason Hulse own after the sale?
A: Murray Jason Hulse’s reported PACS Group holding was 54,574,866 shares following the five transactions. He is identified as the company’s co-founder, CEO and Chairman.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.